Unstable angina non ST elevation myocardial infarction: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 43: | Line 43: | ||
'''Antithrombin Therapy :''' [[Unstable angina / non ST elevation myocardial infarction anticoagulant therapy | Overview]] | [[Unstable angina / NSTEMI unfractionated heparin therapy |Unfractionated Heparin]] | [[Unstable angina / NSTEMI low molecular weight heparin therapy |Low Molecular Weight Heparin]] | [[Unstable angina / NSTEMI direct thrombin inhibitors therapy |Direct Thrombin Inhibitors]] | [[Unstable angina / NSTEMI factor Xa inhibitors therapy |Factor Xa Inhibitors]] | [[Unstable angina / NSTEMI long term anticoagulation therapy |Long Term Anticoagulation]] | [[Unstable angina / NSTEMI ACC/AHA guidelines for anticoagulation therapy|ACC/AHA Guidelines for Anticoagulation]] | '''Antithrombin Therapy :''' [[Unstable angina / non ST elevation myocardial infarction anticoagulant therapy | Overview]] | [[Unstable angina / NSTEMI unfractionated heparin therapy |Unfractionated Heparin]] | [[Unstable angina / NSTEMI low molecular weight heparin therapy |Low Molecular Weight Heparin]] | [[Unstable angina / NSTEMI direct thrombin inhibitors therapy |Direct Thrombin Inhibitors]] | [[Unstable angina / NSTEMI factor Xa inhibitors therapy |Factor Xa Inhibitors]] | [[Unstable angina / NSTEMI long term anticoagulation therapy |Long Term Anticoagulation]] | [[Unstable angina / NSTEMI ACC/AHA guidelines for anticoagulation therapy|ACC/AHA Guidelines for Anticoagulation]] | ||
'''Antitplatelet Agents :''' | '''Antitplatelet Agents :''' [[Unstable angina/NSTEMI Aspirin therapy|Aspirin]] | [[Unstable angina /NSTEMI Thienopyridines|Thienopyridines]] | [[UA / NSTEMI: GPIIb/IIIa inhibitor|Glycoprotein IIb/IIIa Inhibitor]] | ||
[[Unstable angina / non ST elevation myocardial infarction additional management considerations for antiplatelet and anticoagulant therapy | Additional Management Considerations for Antiplatelet and Anticoagulant Therapy]] | [[Unstable angina / non ST elevation myocardial infarction additional management considerations for antiplatelet and anticoagulant therapy | Additional Management Considerations for Antiplatelet and Anticoagulant Therapy]] | ||
'''Mechanical Reperfusion :''' | '''Mechanical Reperfusion :''' [[Unstable angina / non ST elevation myocardial infarction initial conservative versus initial invasive strategies | Initial Conservative Versus Initial Invasive Strategies]] | [[Unstable angina / non ST elevation myocardial infarction recommendations for PCI | PCI]] | [[Unstable angina / non ST elevation myocardial infarction recommendations for CABG | CABG]] | ||
==[[Unstable angina and complications of bleeding and transfusion| | ==Complications of Bleeding and Transfusion== | ||
[[Unstable angina and complications of bleeding and transfusion incidence |Incidence]] | [[Unstable angina and complications of bleeding and transfusion - definitions for bleeding complications |Definitions]] | [[Unstable angina and complications of bleeding and transfusion - predictors and causes of bleeding |Predictors and Causes of Bleeding]] | [[Unstable angina and complications of bleeding and transfusion - blood transfusions |Blood Transfusions]] | [[Unstable angina and complications of bleeding and transfusion prognosis |Prognosis]] | [[Unstable angina and complications of bleeding and transfusion prevention |Prevention]] | [[Unstable angina and complications of bleeding and transfusion recommendations |Recommendations]] | [[Unstable angina and complications of bleeding and transfusion|Overview]] | [[Unstable angina and complications of bleeding and transfusion incidence |Incidence]] | [[Unstable angina and complications of bleeding and transfusion - definitions for bleeding complications |Definitions]] | [[Unstable angina and complications of bleeding and transfusion - predictors and causes of bleeding |Predictors and Causes of Bleeding]] | [[Unstable angina and complications of bleeding and transfusion - blood transfusions |Blood Transfusions]] | [[Unstable angina and complications of bleeding and transfusion prognosis |Prognosis]] | [[Unstable angina and complications of bleeding and transfusion prevention |Prevention]] | [[Unstable angina and complications of bleeding and transfusion recommendations |Recommendations]] | ||
==Discharge Care== | ==Discharge Care== | ||
| Line 56: | Line 56: | ||
==[[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention | Long-Term Medical Therapy and Secondary Prevention]]== | ==[[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention | Long-Term Medical Therapy and Secondary Prevention]]== | ||
[[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention#ACC / AHA Guidelines - Antiplatelet Therapy(DO NOT EDIT)|Antiplatelet Therapy]] | [[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention#ACC / AHA Guidelines - Antiplatelet Therapy(DO NOT EDIT)|Antiplatelet Therapy]] | [[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention#ACC / AHA Guidelines - Beta Blockers(DO NOT EDIT)|Beta Blockers]] | [[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention#ACC / AHA Guidelines - Inhibition Of The Renin-Angiotensin-Aldosterone System(DO NOT EDIT)|Inhibition Of The Renin-Angiotensin-Aldosterone System]] | [[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention#ACC / AHA Guidelines - Nitroglycerin(DO NOT EDIT)|Nitroglycerin Therapy]] | [[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention#ACC / AHA Guidelines - Calcium Channel Blockers(DO NOT EDIT)|Calcium Channel Blockers]] | [[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention#ACC / AHA Guidelines - Warfarin Therapy(DO NOT EDIT)|Warfarin Therapy]] | ||
| [[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention#ACC / AHA Guidelines - Lipid Management(DO NOT EDIT)|Lipid Management]] | [[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention#ACC / AHA Guidelines - Blood Pressure Control(DO NOT EDIT)|Blood Pressure Control]] | [[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention#ACC / AHA Guidelines - Diabetes Mellitus(DO NOT EDIT)|Diabetes Mellitus]] | [[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention#ACC / AHA Guidelines - Smoking Cessation(DO NOT EDIT)|Smoking Cessation]] | [[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention#ACC / AHA Guidelines - Weight Management(DO NOT EDIT)|Weight Management]] | [[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention#ACC / AHA Guidelines - Physical Activity(DO NOT EDIT)|Physical Activity]] | [[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention#ACC / AHA Guidelines - Patient Education(DO NOT EDIT)|Patient Education]] | [[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention#ACC / AHA Guidelines - Influenza Vaccination(DO NOT EDIT)|Influenza Vaccination]] | [[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention#ACC / AHA Guidelines - Depression(DO NOT EDIT)|Depression]] | [[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention#ACC / AHA Guidelines - Nonsteroidal Anti-Inflammatory Drugs(DO NOT EDIT)|Nonsteroidal Anti-Inflammatory Drugs]] | [[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention#ACC / AHA Guidelines - Hormone Therapy(DO NOT EDIT)|Hormone Therapy]] | [[Unstable angina / non ST elevation myocardial infarction long-term medical therapy and secondary prevention#ACC / AHA Guidelines - Antioxidant Vitamins and Folic Acid(DO NOT EDIT)|Antioxidant Vitamins and Folic Acid]] | |||
==Special Groups== | ==Special Groups== | ||
Revision as of 19:33, 13 July 2011
| Unstable angina pectoris | |
| ICD-10 | I20 |
|---|---|
| ICD-9 | 413 |
| DiseasesDB | 8695 |
| eMedicine | med/133 |
| MeSH | D000787 |
|
Unstable angina / NSTEMI Microchapters |
|
Differentiating Unstable Angina/Non-ST Elevation Myocardial Infarction from other Disorders |
|
Special Groups |
|
Diagnosis |
|
Laboratory Findings |
|
Treatment |
|
Antitplatelet Therapy |
|
Additional Management Considerations for Antiplatelet and Anticoagulant Therapy |
|
Risk Stratification Before Discharge for Patients With an Ischemia-Guided Strategy of NSTE-ACS |
|
Mechanical Reperfusion |
|
Discharge Care |
|
Case Studies |
|
Unstable angina non ST elevation myocardial infarction On the Web |
|
FDA on Unstable angina non ST elevation myocardial infarction |
|
CDC onUnstable angina non ST elevation myocardial infarction |
|
Unstable angina non ST elevation myocardial infarction in the news |
|
Blogs on Unstable angina non ST elevation myocardial infarction |
|
to Hospitals Treating Unstable angina non ST elevation myocardial infarction |
|
Risk calculators and risk factors for Unstable angina non ST elevation myocardial infarction |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editors-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]; Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.; Smita Kohli, M.D.; Neil Gheewala, M.D. [3]
Synonyms and related keywords: angina at rest, rest angina, progressive angina, crescendo angina, accelerating angina, new-onset angina, pre-infarction angina, unstable angina pectoris, UAP, UA
Overview
Pathophysiology and Etiology
Unstable Angina | Non-ST Elevation Myocardial Infarction
Epidemiology and Demographics
Risk Factors
Risk Stratification | Guidelines for Early Risk Stratification | Guidelines for Risk Stratification before discharge
Natural history, Complications and Prognosis
Diagnosis
Differential diagnosis | Initial Therapy | History & Symptoms | Physical Examination | Biomarkers | Electrocardiogram | Chest X-Ray | Echocardiography | Coronary Angiography
Treatment
Pre-hospital Care : • Before Onset • After Onset
Immediate Management : Overview | Oxygen | Nitrates | Analgesics | Beta Blockers | Calcium Channel Blocker | Inhibitors of Renin-Angiotensin-Aldosterone axis
Antithrombin Therapy : Overview | Unfractionated Heparin | Low Molecular Weight Heparin | Direct Thrombin Inhibitors | Factor Xa Inhibitors | Long Term Anticoagulation | ACC/AHA Guidelines for Anticoagulation
Antitplatelet Agents : Aspirin | Thienopyridines | Glycoprotein IIb/IIIa Inhibitor
Additional Management Considerations for Antiplatelet and Anticoagulant Therapy
Mechanical Reperfusion : Initial Conservative Versus Initial Invasive Strategies | PCI | CABG
Complications of Bleeding and Transfusion
Overview | Incidence | Definitions | Predictors and Causes of Bleeding | Blood Transfusions | Prognosis | Prevention | Recommendations
Discharge Care
Medical Regimen | Post-Discharge Follow-Up | Cardiac Rehabilitation
Long-Term Medical Therapy and Secondary Prevention
Antiplatelet Therapy | Beta Blockers | Inhibition Of The Renin-Angiotensin-Aldosterone System | Nitroglycerin Therapy | Calcium Channel Blockers | Warfarin Therapy | Lipid Management | Blood Pressure Control | Diabetes Mellitus | Smoking Cessation | Weight Management | Physical Activity | Patient Education | Influenza Vaccination | Depression | Nonsteroidal Anti-Inflammatory Drugs | Hormone Therapy | Antioxidant Vitamins and Folic Acid
Special Groups
Women | Diabetic Patients | Post CABG Patients | Elderly | Chronic Kidney Disease | Drug and Substance Abusers | Prinzmetal's Angina | Cardiovascular Syndrome X
See Also
- The UA / NSTEMI Living Guidelines: Vote on current recommendations and suggest revisions to the guidelines
- Chronic stable angina
- Non ST Elevation Myocardial Infarction
- ST Elevation Myocardial Infarction
Sources
- 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[1]
- The ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction [2]
References
- ↑ Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS (2011). "2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. doi:10.1161/CIR.0b013e318212bb8b. PMID 21444888. Retrieved 2011-04-08. Unknown parameter
|month=ignored (help) - ↑ Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE, Chavey WE, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura R, Ornato JP, Page RL, Riegel B (2007). "ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine". Journal of the American College of Cardiology. 50 (7): e1–e157. doi:10.1016/j.jacc.2007.02.013. PMID 17692738. Retrieved 2011-04-11. Unknown parameter
|month=ignored (help)
External links
- The MD TV: Comments on Hot Topics, State of the Art Presentations in Cardiovascular Medicine, Expert Reviews on Cardiovascular Research
- Clinical Trial Results: An up to date resource of Cardiovascular Research
- Risk Assessment Tool for Estimating Your 10-year Risk of Having a Heart Attack - based on information of the Framingham Heart Study, from the United States National Heart, Lung and Blood Institute
- Heart Attack - overview of resources from MedlinePlus.
- Heart Attack Warning Signals from the Heart and Stroke Foundation of Canada
- Regional PCI for STEMI Resource Center - Evidence based online resource center for the development of regional PCI networks for acute STEMI
- STEMI Systems - Articles, profiles, and reviews of the latest publications involved in STEMI care. Quarterly newsletter.
- American College of Cardiology (ACC) Door to Balloon (D2B) Initiative.
- American Heart Association's Heart Attack web site - Information and resources for preventing, recognizing and treating heart attack.